4AB:FRA
AbbVie Common Stock
261,40 €
arrow_downward
-1,95%(-5,20) 1D
18 նոյ, 22:00:00 GMT+1 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4AB...
Open
265,40 €
High
265,40 €
Low
261,40 €
Mkt. cap
505,56 մլրդ
Avg. vol.
109,00
Volume
26,00
52-wk high
272,30 €
52-wk low
167,55 €
No. of employees
57 հզր
Open
265,40 €
High
265,40 €
Low
261,40 €
Mkt. cap
505,56 մլրդ
Avg. vol.
109,00
Volume
26,00
52-wk high
272,30 €
52-wk low
167,55 €
No. of employees
57 հզր
News stories
From web sources and news partners
Traders Union
·
13 ժամ առաջ
AbbVie stock weekly forecast: Holds gains as buyers stay in control
Investing.com
·
14 ժամ առաջ
Abbvie stock price target raised to $349 by Piper Sandler on growth
The Globe and Mail
·
1 օր առաջ
Barclays Reaffirms Their Buy Rating on AbbVie (ABBV)
WSJ
·
2 շաբաթ առաջ
AbbVie Revenue Rises on Strength in Immunology, Neuroscience
Profile
AbbVie Inc., also known as AbbVie, is an American pharmaceutical company headquartered in North Chicago, Illinois. AbbVie produces drugs to treat a wide range of medical issues.
The company is ranked sixth on the list of largest biomedical companies by revenue. It is ranked 77th on the Fortune 500 and 108th on the Forbes Global 2000. The name "AbbVie" is derived from a combination of "Abbott", the name of its former parent company, with "vie", intended as a reference to a Latin root meaning 'life'. Wikipedia
About AbbVie Common Stock
CEORobert A. Michael
Employees57 հզր
Founded2012 թ. ապր 10
HeadquartersՆորթ Չիկագո, Իլինոյս, Միացյալ Նահանգներ
SectorHealth Care
Industry-
Websiteabbvie.com